Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.41), $0.12 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.